Pfizer’s Xeljanz pill has been approved in the US in psoriatic arthritis, for people who have not responded to, or cannot take, other disease-modifying drugs. Xeljanz has been FDA-approved since ...
Xeljanz, also known as tofacitinib, is a Janus kinase (JAK) inhibitor used for moderate-to-severe ulcerative colitis. JAK ...
Xeljanz (tofacitinib) is approved at the higher dose of 10 mg twice daily in patients with ulcerative colitis, although this can be reduced to 5 mg twice daily in patients who respond well.